These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7630278)

  • 1. Hepatitis B envelope protein mutants.
    McNair AN; Viaggi P; Smith HM; Tibbs CJ; Naoumov NV; Williams R
    Lancet; 1995 Jul; 346(8970):318-9. PubMed ID: 7630278
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B envelope protein mutants.
    Boxall EH
    Lancet; 1995 Jul; 346(8970):319. PubMed ID: 7630279
    [No Abstract]   [Full Text] [Related]  

  • 3. The first identified hepatitis B virus vaccine escape mutation in Turkey.
    Kutlu T; Soycan LY; Karatayli E; Türkyilmaz AR; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2006 Feb; 35(2):201-2. PubMed ID: 16230046
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanisms of hepatitis B e antigen seroconversion from the aspect of viral mutation].
    Torii N; Hasegawa K; Oomori K; Shiratori K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():93-7. PubMed ID: 15453294
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression, purification and characterization of the Hepatitis B virus entire envelope large protein in Pichia pastoris.
    Han X; Ye LB; Li BZ; Bo G; Cai WJ; Hong Z; She YL; Li Y; Kong LB; Wu ZH
    Protein Expr Purif; 2006 Oct; 49(2):168-75. PubMed ID: 16829133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hepatitis B virus mutants on efficacy of vaccination.
    Zuckerman AJ
    Lancet; 2000 Apr; 355(9213):1382-4. PubMed ID: 10791517
    [No Abstract]   [Full Text] [Related]  

  • 7. [The analysis of "a" dominant mutation of hepatitis B virus in community-based population of Shandong Province, China].
    Zhang L; Yan BY; Ji F; Li MS; Song LZ; Xu AQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):424-6. PubMed ID: 21604565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.
    Qin Y; Liao P
    Acta Virol; 2018; 62(2):115-121. PubMed ID: 29895151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and therapeutic significance of hepatitis B virus heterogeneity].
    Campos RH; López JL
    Rev Clin Esp; 2001 Dec; 201(12):713-4. PubMed ID: 11835884
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA-mediated immunization: prospects for hepatitis B vaccination.
    Michel ML
    Res Virol; 1995; 146(4):261-5. PubMed ID: 8539487
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine.
    Gerlich WH; Glebe D
    EBioMedicine; 2016 Sep; 11():5-6. PubMed ID: 27485030
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B virus S gene mutants in infants infected despite immunoprophylaxis.
    Zhu Q; Lu Q; Xiong S; Yu H; Duan S
    Chin Med J (Engl); 2001 Apr; 114(4):352-4. PubMed ID: 11780452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of emergence of hepatitis B virus escape variants: approaches to prevention.
    Thomas HC
    J Viral Hepat; 1998 Nov; 5 Suppl 2():31-6. PubMed ID: 9857358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 15. [Escape mutants of hepatitis B virus].
    Jaramillo CM; Navas MC
    Rev Chilena Infectol; 2015 Apr; 32(2):190-7. PubMed ID: 26065452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for global prevention of hepatitis B virus infection.
    Van Damme P; Zanetti AR; Shouval D; Van Herck K
    Adv Exp Med Biol; 2010; 659():175-88. PubMed ID: 20204764
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy.
    Luongo M; Critelli R; Grottola A; Gitto S; Bernabucci V; Bevini M; Vecchi C; Montagnani G; Villa E
    J Clin Virol; 2015 Jan; 62():89-91. PubMed ID: 25542480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the prospects for controlling hepatitis C?
    Klenerman P; Fleming V; Barnes E
    PLoS Med; 2009 Jun; 6(6):e1000096. PubMed ID: 19529757
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.
    Cassidy A; Mossman S; Olivieri A; De Ridder M; Leroux-Roels G
    Expert Rev Vaccines; 2011 Dec; 10(12):1709-15. PubMed ID: 22085174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.
    Theilmann L; Goeser T
    Hepatogastroenterology; 1991 Feb; 38(1):10-3. PubMed ID: 1709133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.